AQR Capital Management LLC decreased its holdings in UiPath, Inc. (NYSE:PATH - Free Report) by 2.5% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 6,481,228 shares of the company's stock after selling 165,092 shares during the period. AQR Capital Management LLC owned 1.18% of UiPath worth $66,497,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently bought and sold shares of PATH. Advisors Asset Management Inc. boosted its position in shares of UiPath by 570.3% during the first quarter. Advisors Asset Management Inc. now owns 69,406 shares of the company's stock valued at $715,000 after buying an additional 59,052 shares during the period. Amundi boosted its position in shares of UiPath by 7.6% during the first quarter. Amundi now owns 672,171 shares of the company's stock valued at $6,896,000 after buying an additional 47,313 shares during the period. Federation des caisses Desjardins du Quebec boosted its position in shares of UiPath by 41.7% during the first quarter. Federation des caisses Desjardins du Quebec now owns 265,070 shares of the company's stock valued at $2,730,000 after buying an additional 78,005 shares during the period. Perbak Capital Partners LLP purchased a new position in shares of UiPath during the first quarter valued at approximately $183,000. Finally, Focus Partners Advisor Solutions LLC boosted its position in shares of UiPath by 87.9% during the first quarter. Focus Partners Advisor Solutions LLC now owns 23,301 shares of the company's stock valued at $240,000 after buying an additional 10,899 shares during the period. 62.50% of the stock is owned by hedge funds and other institutional investors.
UiPath Stock Up 2.7%
Shares of NYSE PATH traded up $0.31 during mid-day trading on Monday, reaching $11.80. 15,988,423 shares of the company were exchanged, compared to its average volume of 11,748,976. The stock has a market cap of $6.31 billion, a price-to-earnings ratio of 393.27, a P/E/G ratio of 12.07 and a beta of 1.02. UiPath, Inc. has a 1 year low of $9.38 and a 1 year high of $15.93. The firm has a 50-day moving average of $11.74 and a 200 day moving average of $11.79.
UiPath (NYSE:PATH - Get Free Report) last issued its quarterly earnings data on Thursday, September 4th. The company reported $0.15 earnings per share for the quarter, topping analysts' consensus estimates of $0.08 by $0.07. UiPath had a return on equity of 1.27% and a net margin of 1.35%.The firm had revenue of $361.73 million during the quarter, compared to analysts' expectations of $347.36 million. During the same period in the prior year, the business posted $0.04 EPS. The firm's quarterly revenue was up 14.6% on a year-over-year basis. UiPath has set its FY 2026 guidance at EPS. Q3 2026 guidance at EPS. On average, equities analysts forecast that UiPath, Inc. will post -0.17 earnings per share for the current year.
Insider Buying and Selling
In other UiPath news, CEO Daniel Dines sold 9,988 shares of the stock in a transaction dated Thursday, July 31st. The stock was sold at an average price of $12.00, for a total value of $119,856.00. Following the completion of the sale, the chief executive officer directly owned 4,598,388 shares in the company, valued at approximately $55,180,656. This trade represents a 0.22% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders sold 831,310 shares of company stock valued at $10,428,922 in the last three months. Company insiders own 23.19% of the company's stock.
Wall Street Analysts Forecast Growth
Several research analysts have issued reports on PATH shares. Zacks Research upgraded UiPath to a "hold" rating in a research report on Friday, August 8th. Cowen reiterated a "hold" rating on shares of UiPath in a report on Friday. DA Davidson initiated coverage on shares of UiPath in a report on Friday. They issued a "neutral" rating and a $12.00 price target for the company. Wall Street Zen raised shares of UiPath from a "buy" rating to a "strong-buy" rating in a research report on Saturday. Finally, BMO Capital Markets dropped their price objective on shares of UiPath from $15.50 to $12.50 and set a "market perform" rating on the stock in a research note on Friday. Two analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $13.18.
View Our Latest Stock Analysis on PATH
UiPath Company Profile
(
Free Report)
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Recommended Stories

Before you consider UiPath, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.
While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.